2 Reasons Abivax Stock Could 10X by 2036

2026-02-27 15:05:00 ET

Over the trailing-12-month period, shares of French biotech Abivax (NASDAQ: ABVX) have skyrocketed by a little over 1,000%. The company has made tremendous progress with obefazimod, its leading pipeline candidate, which explains this performance. And even after this run, there might be significant upside left for the stock.

Here are two reasons Abivax's stock could 10x over the next decade.

Image source: Getty Images.

Continue reading